Lavelle Capital’s CME Group CME Stock Holding History

Lavelle Capital’s Portfolio CME Stock Details CME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-3,655	Closed	-$998K	–	77
2025 Q4	$998K	Buy	+3,655	New	+$993K	0.63%	36

Other funds holding CME

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Lavelle Capital's CME Position: Q1 2026 in Review

Lavelle Capital sold out of CME Group (CME) in Q1 2026, closing a stake of 3,655 shares — an estimated $998K sold.

Lavelle Capital first reported a position in CME in Q4 2025 and held it in 1 quarter. The position peaked at $998K in Q4 2025. 1,806 funds tracked by Wall St. Rank hold CME as of Q1 2026.

Lavelle Capital reported no remaining CME Group position as of Q1 2026 after selling out during the quarter.
Lavelle Capital sold 3,655 CME Group shares in Q1 2026, an estimated $998K.
Lavelle Capital first reported a position in CME Group in Q4 2025 and held it in 1 quarter.
Lavelle Capital's CME Group position peaked at $998K in Q4 2025.
1,806 funds tracked by Wall St. Rank held CME Group as of Q1 2026.

Based on Lavelle Capital's 13F filing for Q1 2026, filed 28 May 2026.